ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Prostacyclin Drug Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-3I8316
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global and Japan Prostacyclin Drug Market Insights Forecast to 2027
BUY CHAPTERS

Global Prostacyclin Drug Market Research Report 2025

Code: QYRE-Auto-3I8316
Report
July 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
United Therapeutics
Actelion (J & J)
GSK
TEVA
Toray
Tide Pharma
Bayer

Prostacyclin Drug Market Size

The global market for Prostacyclin Drug was valued at US$ 2540 million in the year 2024 and is projected to reach a revised size of US$ 3330 million by 2031, growing at a CAGR of 4.0% during the forecast period.

Prostacyclin Drug Market

Prostacyclin Drug Market

Prostacyclin (also called prostaglandin I2 or PGI2) is a prostaglandin member of the eicosanoid family of lipid molecules. It inhibits platelet activation and is also an effective vasodilator.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Prostacyclin Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostacyclin Drug.
The Prostacyclin Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prostacyclin Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostacyclin Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Prostacyclin Drug Market Report

Report Metric Details
Report Name Prostacyclin Drug Market
Accounted market size in year US$ 2540 million
Forecasted market size in 2031 US$ 3330 million
CAGR 4.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • For Injection
  • For Oral
  • For Inhalation
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company United Therapeutics, Actelion (J & J), GSK, Teva, Toray, Tide Pharma, Bayer AG
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Prostacyclin Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Prostacyclin Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Prostacyclin Drug Market growing?

Ans: The Prostacyclin Drug Market witnessing a CAGR of 4.0% during the forecast period 2025-2031.

What is the Prostacyclin Drug Market size in 2031?

Ans: The Prostacyclin Drug Market size in 2031 will be US$ 3330 million.

Who are the main players in the Prostacyclin Drug Market report?

Ans: The main players in the Prostacyclin Drug Market are United Therapeutics, Actelion (J & J), GSK, Teva, Toray, Tide Pharma, Bayer AG

What are the Application segmentation covered in the Prostacyclin Drug Market report?

Ans: The Applications covered in the Prostacyclin Drug Market report are For Injection, For Oral, For Inhalation

What are the Type segmentation covered in the Prostacyclin Drug Market report?

Ans: The Types covered in the Prostacyclin Drug Market report are Epoprostenol Sodium, Treprostinil, Iloprost, Beraprost Sodium

Recommended Reports

Cardiovascular Drugs

Pharmaceutical Services

Disease and Condition Therapeutics

1 Prostacyclin Drug Market Overview
1.1 Product Definition
1.2 Prostacyclin Drug by Type
1.2.1 Global Prostacyclin Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 Epoprostenol Sodium
1.2.3 Treprostinil
1.2.4 Iloprost
1.2.5 Beraprost Sodium
1.3 Prostacyclin Drug by Application
1.3.1 Global Prostacyclin Drug Market Value by Application (2024 VS 2031)
1.3.2 For Injection
1.3.3 For Oral
1.3.4 For Inhalation
1.4 Global Prostacyclin Drug Market Size Estimates and Forecasts
1.4.1 Global Prostacyclin Drug Revenue 2020-2031
1.4.2 Global Prostacyclin Drug Sales 2020-2031
1.4.3 Global Prostacyclin Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Prostacyclin Drug Market Competition by Manufacturers
2.1 Global Prostacyclin Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Prostacyclin Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Prostacyclin Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Prostacyclin Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Prostacyclin Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prostacyclin Drug, Product Type & Application
2.7 Global Key Manufacturers of Prostacyclin Drug, Date of Enter into This Industry
2.8 Global Prostacyclin Drug Market Competitive Situation and Trends
2.8.1 Global Prostacyclin Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Prostacyclin Drug Players Market Share by Revenue
2.8.3 Global Prostacyclin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Prostacyclin Drug Market Scenario by Region
3.1 Global Prostacyclin Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Prostacyclin Drug Sales by Region: 2020-2031
3.2.1 Global Prostacyclin Drug Sales by Region: 2020-2025
3.2.2 Global Prostacyclin Drug Sales by Region: 2026-2031
3.3 Global Prostacyclin Drug Revenue by Region: 2020-2031
3.3.1 Global Prostacyclin Drug Revenue by Region: 2020-2025
3.3.2 Global Prostacyclin Drug Revenue by Region: 2026-2031
3.4 North America Prostacyclin Drug Market Facts & Figures by Country
3.4.1 North America Prostacyclin Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Prostacyclin Drug Sales by Country (2020-2031)
3.4.3 North America Prostacyclin Drug Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Prostacyclin Drug Market Facts & Figures by Country
3.5.1 Europe Prostacyclin Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Prostacyclin Drug Sales by Country (2020-2031)
3.5.3 Europe Prostacyclin Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prostacyclin Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Prostacyclin Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Prostacyclin Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Prostacyclin Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Prostacyclin Drug Market Facts & Figures by Country
3.7.1 Latin America Prostacyclin Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Prostacyclin Drug Sales by Country (2020-2031)
3.7.3 Latin America Prostacyclin Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prostacyclin Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Prostacyclin Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Prostacyclin Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Prostacyclin Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Prostacyclin Drug Sales by Type (2020-2031)
4.1.1 Global Prostacyclin Drug Sales by Type (2020-2025)
4.1.2 Global Prostacyclin Drug Sales by Type (2026-2031)
4.1.3 Global Prostacyclin Drug Sales Market Share by Type (2020-2031)
4.2 Global Prostacyclin Drug Revenue by Type (2020-2031)
4.2.1 Global Prostacyclin Drug Revenue by Type (2020-2025)
4.2.2 Global Prostacyclin Drug Revenue by Type (2026-2031)
4.2.3 Global Prostacyclin Drug Revenue Market Share by Type (2020-2031)
4.3 Global Prostacyclin Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Prostacyclin Drug Sales by Application (2020-2031)
5.1.1 Global Prostacyclin Drug Sales by Application (2020-2025)
5.1.2 Global Prostacyclin Drug Sales by Application (2026-2031)
5.1.3 Global Prostacyclin Drug Sales Market Share by Application (2020-2031)
5.2 Global Prostacyclin Drug Revenue by Application (2020-2031)
5.2.1 Global Prostacyclin Drug Revenue by Application (2020-2025)
5.2.2 Global Prostacyclin Drug Revenue by Application (2026-2031)
5.2.3 Global Prostacyclin Drug Revenue Market Share by Application (2020-2031)
5.3 Global Prostacyclin Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 United Therapeutics
6.1.1 United Therapeutics Company Information
6.1.2 United Therapeutics Description and Business Overview
6.1.3 United Therapeutics Prostacyclin Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 United Therapeutics Prostacyclin Drug Product Portfolio
6.1.5 United Therapeutics Recent Developments/Updates
6.2 Actelion (J & J)
6.2.1 Actelion (J & J) Company Information
6.2.2 Actelion (J & J) Description and Business Overview
6.2.3 Actelion (J & J) Prostacyclin Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Actelion (J & J) Prostacyclin Drug Product Portfolio
6.2.5 Actelion (J & J) Recent Developments/Updates
6.3 GSK
6.3.1 GSK Company Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Prostacyclin Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GSK Prostacyclin Drug Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Teva
6.4.1 Teva Company Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Prostacyclin Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Teva Prostacyclin Drug Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Toray
6.5.1 Toray Company Information
6.5.2 Toray Description and Business Overview
6.5.3 Toray Prostacyclin Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Toray Prostacyclin Drug Product Portfolio
6.5.5 Toray Recent Developments/Updates
6.6 Tide Pharma
6.6.1 Tide Pharma Company Information
6.6.2 Tide Pharma Description and Business Overview
6.6.3 Tide Pharma Prostacyclin Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Tide Pharma Prostacyclin Drug Product Portfolio
6.6.5 Tide Pharma Recent Developments/Updates
6.7 Bayer AG
6.7.1 Bayer AG Company Information
6.7.2 Bayer AG Description and Business Overview
6.7.3 Bayer AG Prostacyclin Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bayer AG Prostacyclin Drug Product Portfolio
6.7.5 Bayer AG Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prostacyclin Drug Industry Chain Analysis
7.2 Prostacyclin Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prostacyclin Drug Production Mode & Process Analysis
7.4 Prostacyclin Drug Sales and Marketing
7.4.1 Prostacyclin Drug Sales Channels
7.4.2 Prostacyclin Drug Distributors
7.5 Prostacyclin Drug Customer Analysis
8 Prostacyclin Drug Market Dynamics
8.1 Prostacyclin Drug Industry Trends
8.2 Prostacyclin Drug Market Drivers
8.3 Prostacyclin Drug Market Challenges
8.4 Prostacyclin Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
United Therapeutics
Actelion (J & J)
GSK
TEVA
Toray
Tide Pharma
Bayer
List of Tables
 Table 1. Global Prostacyclin Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Prostacyclin Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Prostacyclin Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Prostacyclin Drug Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Prostacyclin Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Prostacyclin Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Prostacyclin Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Prostacyclin Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Prostacyclin Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Prostacyclin Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Prostacyclin Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Prostacyclin Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Prostacyclin Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostacyclin Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Prostacyclin Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Prostacyclin Drug Sales by Region (2020-2025) & (K Units)
 Table 18. Global Prostacyclin Drug Sales Market Share by Region (2020-2025)
 Table 19. Global Prostacyclin Drug Sales by Region (2026-2031) & (K Units)
 Table 20. Global Prostacyclin Drug Sales Market Share by Region (2026-2031)
 Table 21. Global Prostacyclin Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Prostacyclin Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global Prostacyclin Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Prostacyclin Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America Prostacyclin Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Prostacyclin Drug Sales by Country (2020-2025) & (K Units)
 Table 27. North America Prostacyclin Drug Sales by Country (2026-2031) & (K Units)
 Table 28. North America Prostacyclin Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Prostacyclin Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Prostacyclin Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Prostacyclin Drug Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Prostacyclin Drug Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Prostacyclin Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Prostacyclin Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Prostacyclin Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Prostacyclin Drug Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Prostacyclin Drug Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Prostacyclin Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Prostacyclin Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Prostacyclin Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Prostacyclin Drug Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Prostacyclin Drug Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Prostacyclin Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Prostacyclin Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Prostacyclin Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Prostacyclin Drug Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Prostacyclin Drug Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Prostacyclin Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Prostacyclin Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Prostacyclin Drug Sales (K Units) by Type (2020-2025)
 Table 51. Global Prostacyclin Drug Sales (K Units) by Type (2026-2031)
 Table 52. Global Prostacyclin Drug Sales Market Share by Type (2020-2025)
 Table 53. Global Prostacyclin Drug Sales Market Share by Type (2026-2031)
 Table 54. Global Prostacyclin Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Prostacyclin Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Prostacyclin Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global Prostacyclin Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global Prostacyclin Drug Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Prostacyclin Drug Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Prostacyclin Drug Sales (K Units) by Application (2020-2025)
 Table 61. Global Prostacyclin Drug Sales (K Units) by Application (2026-2031)
 Table 62. Global Prostacyclin Drug Sales Market Share by Application (2020-2025)
 Table 63. Global Prostacyclin Drug Sales Market Share by Application (2026-2031)
 Table 64. Global Prostacyclin Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Prostacyclin Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Prostacyclin Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global Prostacyclin Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global Prostacyclin Drug Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Prostacyclin Drug Price (US$/Unit) by Application (2026-2031)
 Table 70. United Therapeutics Company Information
 Table 71. United Therapeutics Description and Business Overview
 Table 72. United Therapeutics Prostacyclin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. United Therapeutics Prostacyclin Drug Product
 Table 74. United Therapeutics Recent Developments/Updates
 Table 75. Actelion (J & J) Company Information
 Table 76. Actelion (J & J) Description and Business Overview
 Table 77. Actelion (J & J) Prostacyclin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Actelion (J & J) Prostacyclin Drug Product
 Table 79. Actelion (J & J) Recent Developments/Updates
 Table 80. GSK Company Information
 Table 81. GSK Description and Business Overview
 Table 82. GSK Prostacyclin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. GSK Prostacyclin Drug Product
 Table 84. GSK Recent Developments/Updates
 Table 85. Teva Company Information
 Table 86. Teva Description and Business Overview
 Table 87. Teva Prostacyclin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Teva Prostacyclin Drug Product
 Table 89. Teva Recent Developments/Updates
 Table 90. Toray Company Information
 Table 91. Toray Description and Business Overview
 Table 92. Toray Prostacyclin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Toray Prostacyclin Drug Product
 Table 94. Toray Recent Developments/Updates
 Table 95. Tide Pharma Company Information
 Table 96. Tide Pharma Description and Business Overview
 Table 97. Tide Pharma Prostacyclin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Tide Pharma Prostacyclin Drug Product
 Table 99. Tide Pharma Recent Developments/Updates
 Table 100. Bayer AG Company Information
 Table 101. Bayer AG Description and Business Overview
 Table 102. Bayer AG Prostacyclin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Bayer AG Prostacyclin Drug Product
 Table 104. Bayer AG Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Prostacyclin Drug Distributors List
 Table 108. Prostacyclin Drug Customers List
 Table 109. Prostacyclin Drug Market Trends
 Table 110. Prostacyclin Drug Market Drivers
 Table 111. Prostacyclin Drug Market Challenges
 Table 112. Prostacyclin Drug Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Prostacyclin Drug
 Figure 2. Global Prostacyclin Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Prostacyclin Drug Market Share by Type: 2024 & 2031
 Figure 4. Epoprostenol Sodium Product Picture
 Figure 5. Treprostinil Product Picture
 Figure 6. Iloprost Product Picture
 Figure 7. Beraprost Sodium Product Picture
 Figure 8. Global Prostacyclin Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Prostacyclin Drug Market Share by Application: 2024 & 2031
 Figure 10. For Injection
 Figure 11. For Oral
 Figure 12. For Inhalation
 Figure 13. Global Prostacyclin Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Prostacyclin Drug Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Prostacyclin Drug Sales (2020-2031) & (K Units)
 Figure 16. Global Prostacyclin Drug Average Price (US$/Unit) & (2020-2031)
 Figure 17. Prostacyclin Drug Report Years Considered
 Figure 18. Prostacyclin Drug Sales Share by Manufacturers in 2024
 Figure 19. Global Prostacyclin Drug Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Prostacyclin Drug Players: Market Share by Revenue in Prostacyclin Drug in 2024
 Figure 21. Prostacyclin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Prostacyclin Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Prostacyclin Drug Sales Market Share by Country (2020-2031)
 Figure 24. North America Prostacyclin Drug Revenue Market Share by Country (2020-2031)
 Figure 25. United States Prostacyclin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Prostacyclin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Prostacyclin Drug Sales Market Share by Country (2020-2031)
 Figure 28. Europe Prostacyclin Drug Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Prostacyclin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Prostacyclin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Prostacyclin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Prostacyclin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Prostacyclin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Prostacyclin Drug Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Prostacyclin Drug Revenue Market Share by Region (2020-2031)
 Figure 36. China Prostacyclin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Prostacyclin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Prostacyclin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Prostacyclin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Prostacyclin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Prostacyclin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Prostacyclin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Prostacyclin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Prostacyclin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Prostacyclin Drug Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Prostacyclin Drug Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Prostacyclin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Prostacyclin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Prostacyclin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Prostacyclin Drug Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Prostacyclin Drug Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Prostacyclin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Prostacyclin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Prostacyclin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Prostacyclin Drug by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Prostacyclin Drug by Type (2020-2031)
 Figure 57. Global Prostacyclin Drug Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Prostacyclin Drug by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Prostacyclin Drug by Application (2020-2031)
 Figure 60. Global Prostacyclin Drug Price (US$/Unit) by Application (2020-2031)
 Figure 61. Prostacyclin Drug Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Prostaglandin I2 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prostaglandins and Related Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prostacyclin Market Research Report 2025
Global Indomethacin Tablets Market Research Report 2024
Global Indometacin Indomethacin Market Research Report 2024
Global PG Hormone Market Research Report 2025
Global Prostaglandin Market Research Report 2025
Global Prostaglandin E2 Market Research Report 2025
Antiplatelet Aggregation Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cyclooxygenase 2 Inhibitor Market Research Report 2024
Global Beraprost Market Research Report 2024
Global Epoprostenol Sodium Drugs Market Insights Forecast to 2030
Global Tafluprost Market Insights Forecast to 2030
Global Iloprost Drugs Market Insights Forecast to 2030
Global Treprostinil Drugs Market Insights Forecast to 2030
Global Indomethacin Market Research Report 2024
Global Prostaglandin endoperoxide Synthase 2 COX 2 Protein Market Research Report 2024
Global Prostaglandin D2 Receptor 2 Market Research Report 2025
Cox 2 Inhibitors Market
Nifedipine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions